CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Mar. 31, 2017
Revenues	$ 214,319	$ 208,357	$ 198,533
Cost of Sales	(202,565)	(197,173)	(187,262)
Gross Profit	11,754	11,184	11,271
Operating Expenses
Selling, distribution and administrative expenses	(8,403)	(8,138)	(7,447)
Research and development	(71)	(125)	(341)
Goodwill impairment charges	(1,797)	(1,738)	(290)
Restructuring and asset impairment charges	(597)	(567)	(18)
Gains from sales of business and on healthcare technology net asset exchange, net	0	109	0
Total Operating Expenses	(10,868)	(10,422)	(4,149)
Operating Income	886	762	7,122
Other Income, Net	182	130	77
Loss on Debt Extinguishment	0	(122)	0
Interest Expense	(264)	(283)	(308)
Income from Continuing Operations Before Income Taxes	610	239	6,891
Income Tax (Expense) Benefit	(356)	53	(1,614)
Income from Continuing Operations	254	292	5,277
Income (Loss) from Discontinued Operations, Net of Tax	1	5	(124)
Net Income	255	297	5,153
Net Income Attributable to Noncontrolling Interests	(221)	(230)	(83)
Net Income Attributable to McKesson Corporation	$ 34	$ 67	$ 5,070
Diluted
Continuing operations (in dollars per share)	$ 0.17	$ 0.30	$ 23.28
Discontinued operations (in dollars per share)	0.00	0.02	(0.55)
Total (in dollars per share)	0.17	0.32	22.73
Basic
Continuing operations (in dollars per share)	0.17	0.30	23.50
Discontinued operations (in dollars per share)	0.00	0.02	(0.55)
Total (in dollars per share)	$ 0.17	$ 0.32	$ 22.95
Weighted Average Common Shares
Diluted (in shares)	197	209	223
Basic (in shares)	196	208	221
Healthcare Technology Net Asset Exchange
Operating Expenses
Gains from sales of business and on healthcare technology net asset exchange, net	$ 0	$ 37	$ 3,947
Change Healthcare
Operating Expenses
Loss from Equity Method Investment in Change Healthcare	$ (194)	$ (248)	$ 0